Results 101 to 110 of about 18,414 (179)
Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants. [PDF]
Kim JD +4 more
europepmc +1 more source
Genotipizacija CYP2C9 u kliničkoj praksi
CYP2C9 jedan je od najvažnijih i najobilnije eksprimiranih enzima sustava citokrom P450 (CYP) u ljudskim jetrima. Odgovoran je za biotransformaciju oko 15 % klinički važnih lijekova, uključujući kumarinske antikoagulante (varfarin), antikonvulzive (fenitoin, valproična kiselina), oralne antidijabetike (gliklazid, tolbutamid), blokatore angiotenzinskih ...
openaire +1 more source
Pharmacogenomics of CYP2D6, CYP2C19, CYP2C9, and Clinical Determinants of Fluoxetine-Norfluoxetine Pharmacokinetics in Real-World Clinical Conditions. [PDF]
de la Cruz CG +5 more
europepmc +1 more source
Identification of diagnostic and prognostic biomarkers in lung adenocarcinoma through integrated bioinformatics analysis and real time PCR validation. [PDF]
Hossein Zadeh R +10 more
europepmc +1 more source

